Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth. With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we have world-class manufacturing facilities in North Carolina and Solothurn, Switzerland. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries. For more information, please visit www.biogen.com. Community Guidelines: https://www.biogen.com/community-guidelines.html Follow us on social media – LinkedIn, Instagram, Facebook, X, and YouTube. Please be cautious of scam recruitment offers claiming to be from Biogen. All legitimate correspondence from a Biogen employee will come from a "@biogen.com" email account. Learn more about scams and fraudulent job postings: https://www.biogen.com/careers/how-we-hire/fraudulent-job-postings.html
Looking for a particular Biogen employee's phone or email?
The Biogen annual revenue was $9.6 billion in 2026.
Alisha Alaimo is the President and Head, North America of Biogen.
9,069 people are employed at Biogen.
Biogen is based in Cambridge, Massachusetts.
The NAICS codes for Biogen are [5417, 3254, 54, 541720, 325, 325414, 541, 32, 32541, 54172].
The SIC codes for Biogen are [283, 28].